Sign In
Buy MRVI
$6.07
-0.160 (-2.57%)
At Close: Aug 10, 2026
Maravai LifeSciences To Host Earnings Conference Call on Tuesday, March 2, 2021
04:15pm, Thursday, 28'th Jan 2021
SAN DIEGO, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences , Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans
Maravai LifeSciences: COVID-19 Beneficiary
06:39am, Monday, 23'rd Nov 2020
Maravai LifeSciences has received a welcome public debut. The company provides a crucial role in drug development and in fact even in the Pfizer/BioNTech vaccine.
U.S. IPO Weekly Recap: Breast Cancer Biotech Pops 158% In A 6-IPO Week
01:07pm, Sunday, 22'nd Nov 2020
In a scramble to go public ahead of the holiday, six IPOs and 15 SPACs went public this past week led by breast cancer biotech Olema Pharmaceuticals, which soared 158% on its first day. New filings co
Maravai LifeSciences Announces Pricing of an Upsized Initial Public Offering
07:50pm, Thursday, 19'th Nov 2020
SAN DIEGO, Calif., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech in
Maravai IPO: What Investors Should Know About Pfizer/BioNTech COVID-19 Vaccine Partner
04:51pm, Thursday, 19'th Nov 2020
Maravai Life Sciences Holdings (NASDAQ:MRVI) will hit the public markets with perfect timing as it sees its mRNA product used by COVID-19 vaccine makers. The Offering: Maravai Life Sciences plans on s
